IL208027A0 - Methods, compositions, and kits for treating pain and pruritus - Google Patents

Methods, compositions, and kits for treating pain and pruritus

Info

Publication number
IL208027A0
IL208027A0 IL208027A IL20802710A IL208027A0 IL 208027 A0 IL208027 A0 IL 208027A0 IL 208027 A IL208027 A IL 208027A IL 20802710 A IL20802710 A IL 20802710A IL 208027 A0 IL208027 A0 IL 208027A0
Authority
IL
Israel
Prior art keywords
pruritus
kits
compositions
methods
treating pain
Prior art date
Application number
IL208027A
Other languages
English (en)
Original Assignee
Harvard College
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Gen Hospital Corp filed Critical Harvard College
Publication of IL208027A0 publication Critical patent/IL208027A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL208027A 2008-03-11 2010-09-07 Methods, compositions, and kits for treating pain and pruritus IL208027A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6901808P 2008-03-11 2008-03-11
PCT/US2009/001541 WO2009114139A2 (en) 2008-03-11 2009-03-11 Methods, compositions, and kits for treating pain and pruritis

Publications (1)

Publication Number Publication Date
IL208027A0 true IL208027A0 (en) 2010-12-30

Family

ID=41065720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208027A IL208027A0 (en) 2008-03-11 2010-09-07 Methods, compositions, and kits for treating pain and pruritus

Country Status (11)

Country Link
US (1) US20110086818A1 (cg-RX-API-DMAC7.html)
EP (1) EP2271329A4 (cg-RX-API-DMAC7.html)
JP (1) JP2011513484A (cg-RX-API-DMAC7.html)
KR (1) KR20110044166A (cg-RX-API-DMAC7.html)
CN (1) CN102112121A (cg-RX-API-DMAC7.html)
AU (1) AU2009223739A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0909627A2 (cg-RX-API-DMAC7.html)
CA (1) CA2717042A1 (cg-RX-API-DMAC7.html)
IL (1) IL208027A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010009951A (cg-RX-API-DMAC7.html)
WO (1) WO2009114139A2 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100099772A1 (en) 2006-11-20 2010-04-22 Bean Bruce P Methods, compositions, and kits for treating pain and pruritis
WO2010085589A2 (en) 2009-01-22 2010-07-29 G&H Brands Llc Desensitizing drug product
EP2451944A4 (en) * 2009-07-10 2012-11-28 Harvard College PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS
JP5832856B2 (ja) * 2010-12-15 2015-12-16 久光製薬株式会社 局所鎮痛作用増強剤及び局所鎮痛キット
EP3363437B8 (en) 2011-02-18 2021-11-03 Endo Pharmaceuticals Inc. Aminoindane compounds and use thereof in treating pain
DK2771320T3 (en) 2011-10-24 2016-10-03 Endo Pharmaceuticals Inc Cyclohexylamines
US8779003B2 (en) 2011-12-29 2014-07-15 Mackay Memorial Hospital Method and composition for prolonging analgesic effect of local anesthetic
WO2014028675A1 (en) 2012-08-15 2014-02-20 Endo Pharmaceuticals Inc. Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
ES2831028T3 (es) 2013-02-08 2021-06-07 Gen Mills Inc Productos alimenticios reducidos en sodio
AU2015247815A1 (en) * 2014-04-14 2016-11-03 Flex Pharma, Inc. Ion channel activators and methods of use
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
CN106214678B (zh) * 2016-07-26 2020-12-29 上海璃道医药科技有限公司 苯酮类药物的用途
WO2018136943A1 (en) 2017-01-23 2018-07-26 Flex Pharma, Inc. Compositions and methods affecting exercise performance
KR101877002B1 (ko) * 2017-03-06 2018-07-12 서울대학교 산학협력단 피라졸 유도체를 유효성분으로 함유하는 소양증의 예방 또는 치료용 약학적 조성물 및 이를 검출하기 위한 스크리닝 방법
KR101867779B1 (ko) * 2017-12-08 2018-06-19 서울대학교산학협력단 피라졸 유도체를 유효성분으로 함유하는 소양증의 예방 또는 치료용 약학적 조성물 및 이를 검출하기 위한 스크리닝 방법
WO2019144139A1 (en) * 2018-01-22 2019-07-25 Oregon State University Immunogenic compositions comprising mycobacterium bovis surface proteins and uses thereof
EP3762034B1 (en) 2018-03-05 2025-08-27 Wylder Nation Foundation A fatty acid amide hydrolase (faahi) inhibitor for use in inhibiting the cellular accumulation of a sphingolipid in a subject that has lysosomal storage disease or disorder
WO2020035555A2 (en) * 2018-08-15 2020-02-20 Pharmacyl Ab Substituted benzamides and their use in therapy
CN109498604A (zh) * 2018-12-24 2019-03-22 复旦大学 香叶醇新用途,预防和治疗非疾病引起的瘙痒症的配制品及方法
CN113924094A (zh) 2019-03-11 2022-01-11 诺西恩医疗公司 酯取代的离子通道阻滞剂及其使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP3937929A4 (en) 2019-03-11 2022-12-28 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2020185881A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
BR112022008575A2 (pt) 2019-11-06 2022-08-09 Nocion Therapeutics Inc Bloqueadores de canal iônico carregado e métodos para uso
EP4054586A4 (en) 2019-11-06 2023-11-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US20230165812A1 (en) * 2020-02-27 2023-06-01 President And Fellows Of Harvard College Nociceptor neurons control cancer immunosurveillance
JP2023515874A (ja) * 2020-03-04 2023-04-14 ノイキュアズ,インコーポレーテッド Trpv1調節物質の投与に関連する交感神経興奮を防止するためのqx314の使用
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20230022830A (ko) 2020-03-11 2023-02-16 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
CN113509457B (zh) * 2020-09-07 2023-03-21 四川昇嘉科技有限公司 山椒素在制备治疗湿疹的药物中的用途
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413961B1 (en) * 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
JP2003516966A (ja) * 1999-12-15 2003-05-20 ユーシィービィ ファルチム ソシエテアノニム 環状4級アンモニウム化合物
CA2446060A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
US7943166B2 (en) * 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
AU2005210637B2 (en) * 2004-01-30 2010-09-16 A.V. Topchiev Institute Of Petrochemical Synthesis Rapidly dissolving film for delivery of an active agent
EP1763370B1 (en) * 2004-06-02 2015-04-29 NeurogesX Inc. Formulations comprising capsaicin, a local anesthetic and/or an antipruritic agent for the treatment of pain
US20100099772A1 (en) * 2006-11-20 2010-04-22 Bean Bruce P Methods, compositions, and kits for treating pain and pruritis

Also Published As

Publication number Publication date
CN102112121A (zh) 2011-06-29
KR20110044166A (ko) 2011-04-28
BRPI0909627A2 (pt) 2018-04-10
WO2009114139A2 (en) 2009-09-17
AU2009223739A1 (en) 2009-09-17
US20110086818A1 (en) 2011-04-14
EP2271329A4 (en) 2013-01-09
CA2717042A1 (en) 2009-09-17
WO2009114139A3 (en) 2009-12-23
JP2011513484A (ja) 2011-04-28
MX2010009951A (es) 2011-09-01
EP2271329A2 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
IL208027A0 (en) Methods, compositions, and kits for treating pain and pruritus
IL257418A (en) Methods for treating addiction
IL248652A0 (en) Methods, compositions and devices for facilitating re-creation
SMT202300082T1 (it) Metodi e composizioni per il trattamento dei disturbi associati al complemento
ZA201101055B (en) Compositions and methods for treating osteoarthritis
IL205704A0 (en) Compositions and methods for treating purpura
IL202015A0 (en) Methods and compositions for treating skin conditions
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2282826A4 (en) PROCESS FOR TREATMENT OF ODOR
IL212348A0 (en) Treatment method
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
IL200889A0 (en) Compositions and kits for treating influenza
WO2012054862A9 (en) Agents, compositions, and methods for treating pruritis and related skin conditions
IL207132A0 (en) Composition and method for seed treatment use
EP2355660A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
EP2231185A4 (en) METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS
ZA201106577B (en) Compounds and compositions for cognition-enhancement,methods of making,and methods of treating
EP2035015A4 (en) COMPOSITIONS, METHODS AND KITS FOR DRY EYE TREATMENT
GB0800570D0 (en) Composition, process for preparation and method of use
PT2318573T (pt) Método de tratamento anticorrosão
PL2262828T3 (pl) Kompozycje, sposoby i zestawy
ZA201101520B (en) Phenanthrenone compounds,compositions and methods
HK1151742A (en) Methods, compositions, and kits for treating pain and pruritis
ZA201000867B (en) Methods for treating dependence
HK1148947A (en) Method for treating addiction using quercetin-containing compositions